Abstract A recombinant infectious bronchitis virus (IBV), BeauR-M41(S), was generated using our reverse genetics system (R. Casais, V. Thiel, SG Siddell, D. Cavanagh and P. […]
Zaire ebolavirus Recombinants
Abstract Over the past 30 years, Zaire ebolavirus (ZEBOV) recombinant, a highly pathogenic virus for humans and wild apes, has repeatedly emerged in Central Africa. […]
Drosophila melanogaster Recombinants
Abstract Recombination of Drosophila melanogaster is a fundamental biological process with profound evolutionary implications. Theory predicts that recombination increases the efficiency of selection in natural […]
100 mM dUTP
Thermo Scientific dUTP (2′-deoxyuridine 5′-triphosphate) is a very stable nucleotide supplied as a 100 mM aqueous solution titrated to pH 7.3-7.5 with NaOH. The nucleotide […]
ZENA SARS-CoV-2 Direct Detection Kit
General description: The novel SARS-CoV-2 (COVID-19) is a severe acute respiratory syndrome coronavirus that is responsible for respiratory disease and was first detected in Wuhan […]
Polyethylenimine, Linear
Properties Quality level: 100 Molecular weight: average Mn 10,000 Deputy: 48-53 ° C POI: ≤1.3 Storage temperature: 2-8 ° C InChI: 1S / C2H5N / […]
Plasmid-250-mini Plasmid DNA Extraction Kit
The PureLink HQ Mini Plasmid Purification Kit is designed for the isolation of high-quality plasmid DNA that is suitable for restriction enzyme digestion, PCR, sequencing, […]
COVID-19 PCR Diagnostic
CDC Diagnostic Tests for COVID-19 The CDC has developed two laboratory tests that identify SARS-CoV-2, the virus that causes COVID-19. The first COVID-19 diagnostic test […]
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor.
PARP inhibitors are being developed as therapeutic brokers for most cancers. Greater than six compounds have entered scientific trials. The vast majority of these compounds […]
Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment.
Impaired DNA harm response pathways might create vulnerabilities of most cancers cells that may be exploited therapeutically. One such selective vulnerability is the sensitivity of […]